trending Market Intelligence /marketintelligence/en/news-insights/trending/1Eozk8PkO37sDgpsb6M5Wg2 content esgSubNav
In This List

Marapharm to sell cannabis license, assets to Standard Graphite

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Marapharm to sell cannabis license, assets to Standard Graphite

Marapharm Ventures Inc. unit Marapharm Inc. plans to sell its Canadian medical cannabis license to Standard Graphite Corp.

Standard Graphite will issue C$5.3 million worth of its shares for the license, plus other Marapharm assets, including 7 acres of property in Nevada and facilities in Washington and California.

Standard Graphite will issue a further C$2.5 million worth of shares if the deal is approved by Health Canada.

Marapharm also has 15 million shares and warrants of Veritas Pharma Inc.